Considerations before the legalization of recreational and medical cannabis in Iran

被引:1
|
作者
Shamabadi, Ahmad [1 ]
Akhondzadeh, Shahin [1 ]
机构
[1] Univ Tehran Med Sci, Psychiat Res Ctr, Roozbeh Psychiat Hosp, South Kargar St, Tehran 13337, Iran
关键词
Decision making; Marijuana; Psychiatric disorder; Substance related disorder; Tetrahydrocannabinol;
D O I
10.1016/j.ajp.2024.104237
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cultural perspectives on marijuana consumption have undergone substantial reforms in recent years, and the decriminalization and legalization of cannabis are a matter of debate now. The conditions of determining factors are not the same among societies; therefore, each society should decide independently. Herein, the considerations that Iran should contemplate before legalizing cannabis were addressed. Global trends, social status, influence on the judiciary, costs, health effects, quality control, shifting substance use patterns, societal detachment, and changes in prevalence were the discussed determinant factors. Now that religious, cultural, and legal status has suppressed the increase in prevalence, legalization of recreational use that leads to a significant increase in consumption is not advisable. However, the legalization and production of medical cannabis should be on the agenda, as none of the items that hinder the legalization of recreational cannabis do not apply to medical cannabis. Research should continue to reduce uncertainties, especially by combining big data from sale systems of areas where recreational cannabis use has been legalized with big data sources like social media.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Legalization of cannabis for medical and recreational use
    Hasin, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [2] Legalization of cannabis for medical and recreational use
    Hasin, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [3] Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality
    Nguyen, Hai V.
    McGinty, Emma E.
    Mital, Shweta
    Alexander, G. Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 16 - 16
  • [4] Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality
    Nguyen, Hai V.
    McGinty, Emma E.
    Mital, Shweta
    Alexander, G. Caleb
    JAMA HEALTH FORUM, 2024, 5 (01): : E234897
  • [5] Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada
    Nguyen, Hai V.
    Grootendorst, Paul
    Mital, Shweta
    Bishop, Lisa
    McGinty, Emma E.
    CANNABIS AND CANNABINOID RESEARCH, 2024, 9 (01) : 335 - 342
  • [6] Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia
    Chiu, Vivian
    Chan, Gary
    Hall, Wayne
    Hides, Leanne
    Lim, Carmen
    Leung, Janni
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [7] Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain
    Geoffrion, Roxana
    Yang, Emily C.
    Koenig, Nicole A.
    Brotto, Lori A.
    Barr, Alasdair M.
    Lee, Terry
    Allaire, Catherine
    Bedaiwy, Mohamed A.
    Yong, Paul J.
    OBSTETRICS AND GYNECOLOGY, 2021, 137 (01): : 91 - 99
  • [8] Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry
    Humphreys, Keith
    Shover, Chelsea L.
    WORLD PSYCHIATRY, 2020, 19 (02) : 191 - 192
  • [9] The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer
    Hawley, Philippa
    Gobbo, Monica
    Afghari, Narsis
    BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)
  • [10] Medicalization without legalization: the European policy for medical and recreational cannabis use
    Farber, Yair
    Nir, Oksana
    Farber, Shai
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2024,